A method for detection or
monitoring status of
traumatic brain injury (TBI) and / or
spinal cord injury (SCI) in a subject is provided. In one embodiment, the method comprises contacting a specimen of bodily fluid obtained from the subject with reagents for assaying for a marker of TBI selected from aldolase C (ALDOC) and brain
lipid binding protein (BLBP / FABP7), or a trauma-specific break down product (BDP) of ALDOC or BLBP / FABP7. The method further comprises measuring the amount of marker present in the specimen as compared to a
control sample, and determining the presence of TBI or SCI when an elevated amount of marker is present in the specimen compared to the
control sample. Optionally, the method further comprises measuring the amount of
glutamine synthetase (GS), astrocytic
phosphoprotein PEA-15 (PEA15), αB-crystallin (CRYAB / HSP27), a trauma-specific proteolytic cleavage product of ALDOC, GS, PEA15, or CRYAB, or any combination of two or more thereof.